HCPCS Level II C9606: Percutaneous Revascularization for Acute MI, Single Vessel
HCPCS Level II code C9606 describes percutaneous transluminal revascularization for acute total or subtotal coronary occlusion during an acute myocardial infarction, performed on a single vessel and may include drug-eluting intracoronary stent placement, atherectomy, angioplasty, and aspiration thrombectomy when performed; service type: percutaneous coronary intervention for acute MI; typical site of service: cardiac catheterization laboratory or interventional cardiology suite in an acute care hospital or catheterization center.
For related coverage guidance, see recent payer policy updates: Cardiac Computed Tomography (CCT)/Coronary Computed Tomographic Angiography (CCTA), Cardiovascular Disease Risk Assessment, Biomarkers for Myocardial Infarction and Chronic Heart Failure.
Customize your policy alerts
Sign up for hcpcs C9606 policy alerts
Get alerted when payer policies referencing C9606 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial pricing for HCPCS C9606 clusters around an average commercial (BUCA) mean of $5,791 with a median of $3,855, indicating a skew toward higher outliers. Among named payers, Cigna and Blue Cross Blue Shield show the highest central tendencies (Cigna median $14,000; BCBS median $1,256.50), while Aetna and UnitedHealth Group have much lower medians ($688 and $2,086 respectively), reflecting substantial variation in typical reimbursement levels across insurers.
Dispersion measured as P75 minus P25 highlights where rates are most and least concentrated: Blue Cross Blue Shield has the widest interquartile spread at $7,748 (P75 $8,014 minus P25 $726.60), closely followed by Cigna at $13,183 (P75 $21,424 minus P25 $7,241.10) and UnitedHealth Group at $6,312 (P75 $7,018.90 minus P25 $706.50). Aetna is the tightest with a spread of $344 (P75 $688 minus P25 $344), indicating much narrower variability in commercial payments.